Anthropometric evaluation in patients with metabolic syndrome using a beverage enriched with beta-glucan from white oats and dry extract of yerba mate

Main Article Content

Júlia Pess dos Santos
Viviane Fereira de Melo
Greissi Tatieli Franke Tremêa
Paula Lorenzoni Nunes
Mariana Moura Ercolani Novack
José Antônio Gonzalez da Silva
Ivan Ricardo Carvalho
Euclides Lara Cardozo Junior
Christiane de Fátima Colet

Abstract

Introduction: White oat (Avena sativa L.) and yerba mate (Ilex paraguariensis) have been studied due to bioactive compounds and functional capacities that may be associated with the reduction of cardiovascular risk. Objective: To evaluate the effects on anthropometric and clinical parameters of white oat beta-glucan and standardized dry extract of yerba mate in the treatment of metabolic syndrome. Methods: Experimental and analytical, prospective, randomized, double-blind clinical trial type. Clinical variables: blood pressure and anthropometric variables weight, BMI, waist, and abdominal circumference were analyzed in patients with Metabolic Syndrome using a drink enriched with oat beta-glucan and standardized dry extract of yerba mate. For the association, a test to compare means was used for samples paired by Student's t-test and ANOVA test. Results: The study was completed by 25 participants. Those who used a shake enriched with standardized dry extract of yerba mate and a shake enriched with beta-glucan and standardized dry extract of yerba mate had a reduction in BP; this study did not have a significant impact on body weight, waist and abdominal circumferences, and waist-to-hip ratio. For the evaluation of body muscle mass, the standardized dry extract of yerba mate showed a significant increase in one of the research times. Conclusion: The use of beta-glucan from oats and standardized dry extract of yerba mate may be promising for the treatment and risk reduction of MS, since its use had a positive impact on the reduction of systolic and diastolic blood pressure in the participants.

Downloads

Download data is not yet available.

Article Details

How to Cite
Santos, J. P. dos, Melo, V. F. de, Tremêa, G. T. F., Nunes, P. L., Novack, M. M. E., Silva, J. A. G. da, … Colet, C. de F. (2026). Anthropometric evaluation in patients with metabolic syndrome using a beverage enriched with beta-glucan from white oats and dry extract of yerba mate. ABCS Health Sciences. https://doi.org/10.7322/abcshs.2025025.3201
Section
Original Articles

References

1. Carvalho MHC. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005;84(Suppl 1):3-28. https://doi.org/10.1590/S0066-782X2005000700001

2. Saklayen MG. The global epidemic of metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https://doi.org/10.1007/s11906-018-0812-z

3. Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6(2):109-20. https://doi.org/10.14336/AD.2014.0305

4. Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):158. https://doi.org/10.1002/cphy.c110062

5. Cloetens L, Ulmius M, Johansson-Persson A, Åkesson B, Önning G. Role of dietary beta-glucans in the prevention of the metabolic syndrome. Nutr Rev. 2012;70(8):444-58. https://doi.org/10.1111/j.1753-4887.2012.00494.x

6. Cardozo Junior EL, Morand C. Interest of mate (Ilex paraguariensis A. St.-Hil.) as a new natural functional food to preserve human cardiovascular health - Review. J Funct Foods. 2016;21:440-54. https://doi.org/10.1016/j.jff.2015.12.010

7. Liao MY, Shen YC, Chiu HF, Ten SM, Lu YY, Han YC, et al. Down-regulation of partial substitution for staple food by oat noodles on blood lipid levels: A randomized, double-blind, clinical trial. J Food Drug Anal. 2019;27(1):93-100. https://doi.org/10.1016/j.jfda.2018.04.001

8. Vasconcellos AC, Frazzon J, Noreña CPZ. Phenolic compounds present in Yerba mate potentially increase human health: A critical review. Plant Foods Hum Nutr. 2022;77(4):495-503. https://doi.org/110.1007/s11130-022-01008-8

9. Heck CI, Mejia EG. Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations. J Food Sci. 2007;72(9):R138-51. https://doi.org/10.1111/j.1750-3841.2007.00535.x

10. Bracesco N, Sanchez AG, Contreras V, Menini T, Gugliucci A. Recent advances on Ilex paraguariensis research: Minireview. J Ethnopharmacol. 2011;136(3):378-84. https://doi.org/10.1016/j.jep.2010.06.032

11. Gebara KS, Gasparotto Junior A, Palozi RA, Morand C, Bonetti CI, Gozzi PT, et al. A randomized crossover intervention study on the effect of a standardized maté extract (Ilex paraguariensis A. St.-Hil.) in men predisposed to cardiovascular risk. Nutrients. 2020;13(1):14. https://doi.org/10.3390/nu13010014

12. Ho HVT, Sievenpiper JL, Zurbau A, Mejia SB, Jovanovski E, Au-Yeung F, et al. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr. 2016;116(8):1369-82. https://doi.org/10.1017/S000711451600341X

13. Sima P, Vannucci L, Vetvicka V. β-glucans and cholesterol (Review). Int J Mol Med. 2018;41(4):1799-808. https://doi.org/10.3892/ijmm.2018.3411

14. Whitehead A, Beck EJ, Tosh S, Wolever TMS. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100(6):1413-21. https://doi.org/10.3945/ajcn.114.086108

15. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome: a new world‐wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med. 2006;23(5):469-80. https://doi.org/10.1111/j.1464-5491.2006.01858.x

16. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Orientações para a coleta e análise de dados antropométricos em serviços de saúde: Norma Técnica do Sistema de Vigilância Alimentar e Nutricional – SISVAN. Brasília: Ministério da Saúde, 2011.

17. Li L, Su C, Chen X, Wang Q, Jiao W, Luo H, et al. Chlorogenic acids in cardiovascular disease: A review of dietary consumption, pharmacology, and pharmacokinetics. J Agric Food Chem. 2020;68(24):6464-84. https://doi.org/10.1021/acs.jafc.0c01554

18. Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Diretrizes brasileiras de hipertensão arterial–2020. Arq Bras Cardiol. 2021;116(3):516-658. https://doi.org/10.36660/abc.20201238

19. Redondo-Puente M, Mateos R, Seguido MA, García-Cordero J, González S, Tarradas RM, et al. Appetite and satiety effects of the acute and regular consumption of green coffee phenols and green coffee phenol/oat β-glucan nutraceuticals in subjects with overweight and obesity. Foods. 2021;10(11):2511. https://doi.org/10.3390/foods10112511

20. Tan Q, Li Y, Guo Y. Exercício físico melhora as funções das células progenitoras endoteliais em pacientes com síndrome metabólica. Arq Bras Cardiol. 2021;117(1):108-17. https://doi.org/10.36660/abc.20200028

21. Blank JT, Helena ETS, Damasceno RNT, Santos RD, Markus MRP, Azevedo LC. Consumo de carnes por adultos e idosos de uma cidade de colonização alemã do sul do Brasil: estudo de base populacional. Cienc Saude Coletiva. 2023;28(1):243-55. https://doi.org/10.1590/1413-81232023281.01932022

22. Valença HM, Silva CPE, Gitirana LB, Valença SS, Lanzetti M. Beneficial effects of Ilex paraguariensis in the prevention of obesity‐associated metabolic disorders in mice. Phytother Res. 2022;36(2):1032-42. https://doi.org/10.1002/ptr.7377

23. Ibrahim Q, Ahsan M. Measurement of Visceral Fat, Abdominal Circumference and Waist-hip Ratio to Predict Health Risk in Males and Females. Pak J Biol Sci. 2019;22(4):168-73. https://doi.org/10.3923/pjbs.2019.168.173

24. Ferreira MG, Valente JG, Gonçalves-Silva RMV, Sichieri R. Acurácia da circunferência da cintura e da relação cintura/quadril como preditores de dislipidemias em estudo transversal de doadores de sangue de Cuiabá, Mato Grosso, Brasil. Cad Saude Publica. 2006;22(2):307-14. https://doi.org/10.1590/S0102-311X2006000200008

25. Nehmi-Filho V, Santamarina AB, Freitas JA, Trarbach EB, Oliveira DR, Palace-Berl F, et al. Novel nutraceutical supplements with yeast β-glucan, prebiotics, minerals, and Silybum marianum (silymarin) ameliorate obesity-related metabolic and clinical parameters: A double-blind randomized trial. Front Endocrinol (Lausanne). 2023;13:1089938. https://doi.org/10.3389/fendo.2022.1089938

26. Mussoi TD, Blümke AC, Benedetti FJ, Souza JC. Avaliação nutricional na prática clínica: da gestação ao envelhecimento. Rio de Janeiro: Guanabara Koogan, 2014.

27. Oliveira AP, Bernardes ACB, Fernandes FLF, Tiengo A. Avaliação dos efeitos de fitoterápicos termogênicos em parâmetros antropométricos de pacientes com sobrepeso e obesidade. Rev Bras Obes Nutr Emagrecimento. 2017;11(68):667-76.

28. Timóteo S, Correia M, Rodríguez-Echeverría S, Freitas H, Heleno R. Multilayer networks reveal the spatial structure of seed-dispersal interactions across the Great Rift landscapes. Nat Commun. 2018;9(1):140. https://doi.org/10.1038/s41467-017-02658-y